| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $38.6M | — | -26.0% |
| SG&A Expense | $14.3M | — | -24.1% |
| Operating Income | -$52.9M | — | +25.5% |
| Interest Expense | $1.4M | — | — |
| Pre-tax Income | -$53.4M | — | +21.3% |
| Income Tax | $30K | — | -71.4% |
| Net Income | -$53.5M | — | +21.4% |
| EPS (Basic) | -$0.30 | — | +28.6% |
| EPS (Diluted) | -$0.30 | — | +28.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $147.1M | -19.4% | +15.9% |
| Current Assets | $153.4M | -19.5% | -39.8% |
| Total Assets | $153.9M | -19.5% | -40.1% |
| Current Liabilities | $30.1M | -7.2% | +6.1% |
| Long-term Debt | $53.0M | -2.9% | — |
| Total Liabilities | $83.2M | -4.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$46.4M | — | +21.9% |
| Investing Cash Flow | $71K | — | -99.8% |
| Financing Cash Flow | $10.9M | — | — |
| +193.1% |
| Stockholders' Equity | $70.7M | -32.0% | -69.0% |